BackTakeda Pharmaceutical Overview

Takeda Pharmaceutical Total Assets

Track Takeda Pharmaceutical's total assets ($15T) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$15271.50B
↑ 5.54% YoYΔ $801.20B vs prior year quarter

Peer trimmed avg / median

Loading

Takeda Pharmaceutical Total Assets History

Loading

Takeda Pharmaceutical vs. peers: Total Assets Comparison

Loading

Takeda Pharmaceutical Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Takeda Pharmaceutical (TAK) FAQ

Takeda Pharmaceutical posts a total assets of $15T as of September 2026. That compares with $14T in the prior-year period — up 5.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Takeda Pharmaceutical's total assets was $14T. The latest reading is $15T — a 5.5% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Takeda Pharmaceutical's financial statement story. At $15T, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for TAK's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Takeda Pharmaceutical's other metric pages and overview cover the third.

Judging Takeda Pharmaceutical against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total assets easier to interpret. Start with $15T here, then scan peer and history charts to see if the gap is persistent.